POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	2b3x	IRON-RESPONSIVE ELEMENT BINDING PROTEIN 1 (Homo sapiens)	5 / 12	VAL A 130 VAL A 498 THR A 438 THR A 440 LEU A 551	None	0.99A	9.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	2gk9	PHOSPHATIDYLINOSITOL -4-PHOSPHATE 5-KINASE, TYPE II, GAMMA (Homo sapiens)	5 / 12	PHE A 100 LEU A  62 THR A 127 GLY A 187 LEU A  47	None	1.06A	15.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	2vre	DELTA(3,5)-DELTA(2,4 )-DIENOYL-COA ISOMERASE (Homo sapiens)	5 / 12	VAL A 189 LEU A 186 VAL A 150 GLY A 215 LEU A 234	None None None CL  A1290 ( 3.7A) None	1.15A	17.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	3f92	UBIQUITIN-CONJUGATIN G ENZYME E2 K (Homo sapiens)	5 / 12	VAL A  16 LEU A 106 VAL A 109 THR A  77 VAL A  73	None	0.80A	19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	3she	MAP KINASE-ACTIVATED PROTEIN KINASE 3 (Homo sapiens)	5 / 12	LEU A 115 VAL A 103 VAL A  85 GLY A  56 LEU A 173	None	1.05A	17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	3shu	TIGHT JUNCTION PROTEIN ZO-1 (Homo sapiens)	5 / 12	VAL A  35 LEU A  20 VAL A  18 VAL A  81 GLY A  45	None	1.03A	27.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	3u1k	POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERA SE 1, MITOCHONDRIAL (Homo sapiens)	5 / 12	VAL A 472 LEU A 425 THR A 550 THR A 555 GLY A 490	None	1.05A	13.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	3wbg	FATTY ACID-BINDING PROTEIN, HEART (Homo sapiens)	6 / 12	PHE A  16 VAL A  32 THR A  53 LEU A 115 ARG A 126 TYR A 128	2AN  A 201 ( 4.9A) None 2AN  A 201 ( 4.0A) None 2AN  A 201 ( 4.9A) None	0.87A	39.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	4b92	DIHYDROPYRIMIDINASE- RELATED PROTEIN 5 (Homo sapiens)	5 / 12	PHE A 373 VAL A 403 VAL A 435 THR A 273 LEU A 314	None	1.16A	13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	4cak	INTEGRIN ALPHA-IIB (Homo sapiens)	5 / 12	LEU A 786 VAL A 748 THR A 793 VAL A 794 GLY A 822	None	1.17A	8.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	4rkk	LAFORIN (Homo sapiens)	5 / 12	VAL A 292 LEU A 296 VAL A 303 THR A 238 GLY A 279	None	1.13A	16.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	5b29	FATTY ACID-BINDING PROTEIN, HEART (Homo sapiens)	5 / 12	VAL A  25 THR A  53 LEU A 115 ARG A 126 TYR A 128	None PLM  A 200 ( 4.2A) None PLM  A 200 (-3.7A) PLM  A 200 (-4.8A)	0.80A	40.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	5dfl	UBIQUITIN-CONJUGATIN G ENZYME E2 K (Homo sapiens)	5 / 12	VAL A  16 LEU A 106 VAL A 109 THR A  77 VAL A  73	None None None None GOL  A 301 (-4.4A)	0.77A	19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	5i35	ATYPICAL KINASE ADCK3, MITOCHONDRIAL (Homo sapiens)	5 / 12	VAL A 300 LEU A 267 VAL A 270 GLY A 278 TYR A 408	None	1.17A	15.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	5nug	CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1 (Homo sapiens)	5 / 12	PHE A4145 VAL A4055 THR A4039 ARG A4123 GLY A4032	None	1.07A	2.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	5tzy	FREE FATTY ACID RECEPTOR 1,ENDOLYSIN,FREE FATTY ACID RECEPTOR 1 (Escherichia virus T4; Homo sapiens)	5 / 12	VAL A 134 LEU A 190 GLY A  93 LEU A  59 TYR A  12	7OS  A2403 (-4.6A) 7OS  A2403 (-4.3A) None None None	1.14A	15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	5xau	LAMININ SUBUNIT ALPHA-5 (Homo sapiens)	5 / 12	PHE A3258 VAL A3288 LEU A3133 VAL A3265 GLY A3291	None	1.09A	12.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CBR_A_A80A201_1 (PROTEIN (CRABP-I))	6db7	HUMAN MONOCLONAL ANTI-HIV-1 GP120 V3 ANTIBODY 1334 FAB HEAVY CHAIN (Homo sapiens)	5 / 12	VAL H  67 LEU H  82 VAL H  18 VAL H 109 LEU H   4	None	1.17A	19.12